Table 2. Outcomes Patient no. .... | American Society of Hematology

Table 2.

Outcomes

Patient no.	Neutrophils > 0.5 × 10⁹/L	Platelets > 20 × 10⁹/L	Acute GVHD	Chronic GVHD	Follow-up (days)	Current disease status	Cause of death
1	13	—	0	NE	26	Dead	IP
2	10	15	0	0	830	CR
3	18	30	0	0	801	CR
4	11	10	I	L	736	Relapse
5	14	18	0	0	708	CR
6	14	19	0	L	391	Dead	Prog
7	14	18	III	0	142	Dead	Prog
8	12	12	0	0	563	Relapse
9	15	10	I	L	540	CR
10	10	13	II	0	511	PR^*
11	17	15	0	0	515	CR
12	12	14	0	0	505	PR^*
13	10	29	0	0	492	CR
14	14	17	0	0	485	CR
15	12	—	0	NE	18	Dead	Multiorgan failure
16	12	16	I	0	404	Dead	Perforated DU
17	12	16	0	0	428	CR
18	10	9	0	0	420	PR^*
19	10	14	0	NE	16	Dead	IFI
20	11	14	0	0	366	Prog
21	14	20	0	NE	49	Dead	PFIII
22	13	18	II	0	156	Dead	EBV LPD
23	11	12	II	0	359	CR
24	10	12	I	0	351	CR
25	15	12	I	0	347	CR
26	13	13	II	0	341	PR^*
27	15	—	I	0	110	Dead	Cerebral toxoplasmosis
28	13	18	0	0	305	Relapse
29	11	19	0	NE	52	Dead	Multiorgan failure
30	^†	^†	0	0	248	CR
31	12	21	0	0	227	PR
32	15	13	0	0	119	Dead	Prog
33	15	15	0	0	220	PR
34	13	20	III	0	212	CR
35	17	23	0	0	232	CR
36	15	—	0	NE	52	Dead	IP
37	13	19	I	0	199	Prog
38	18	23	0	0	199	Prog
39	10	17	0	0	198	CR
40	^†	^†	0	0	186	CR
41	11	15	0	NE	53	Dead	CMV Pn
42	16	51	II	0	168	CR
43	17	18	0	0	120	CR
44	14	—	II	0	109	PR
45	15	20	0	0	108	CR
46	13	20	III	NE	99	NE
47	16	11	II	NE	79	NE

Patient no.	Neutrophils > 0.5 × 10⁹/L	Platelets > 20 × 10⁹/L	Acute GVHD	Chronic GVHD	Follow-up (days)	Current disease status	Cause of death
1	13	—	0	NE	26	Dead	IP
2	10	15	0	0	830	CR
3	18	30	0	0	801	CR
4	11	10	I	L	736	Relapse
5	14	18	0	0	708	CR
6	14	19	0	L	391	Dead	Prog
7	14	18	III	0	142	Dead	Prog
8	12	12	0	0	563	Relapse
9	15	10	I	L	540	CR
10	10	13	II	0	511	PR^*
11	17	15	0	0	515	CR
12	12	14	0	0	505	PR^*
13	10	29	0	0	492	CR
14	14	17	0	0	485	CR
15	12	—	0	NE	18	Dead	Multiorgan failure
16	12	16	I	0	404	Dead	Perforated DU
17	12	16	0	0	428	CR
18	10	9	0	0	420	PR^*
19	10	14	0	NE	16	Dead	IFI
20	11	14	0	0	366	Prog
21	14	20	0	NE	49	Dead	PFIII
22	13	18	II	0	156	Dead	EBV LPD
23	11	12	II	0	359	CR
24	10	12	I	0	351	CR
25	15	12	I	0	347	CR
26	13	13	II	0	341	PR^*
27	15	—	I	0	110	Dead	Cerebral toxoplasmosis
28	13	18	0	0	305	Relapse
29	11	19	0	NE	52	Dead	Multiorgan failure
30	^†	^†	0	0	248	CR
31	12	21	0	0	227	PR
32	15	13	0	0	119	Dead	Prog
33	15	15	0	0	220	PR
34	13	20	III	0	212	CR
35	17	23	0	0	232	CR
36	15	—	0	NE	52	Dead	IP
37	13	19	I	0	199	Prog
38	18	23	0	0	199	Prog
39	10	17	0	0	198	CR
40	^†	^†	0	0	186	CR
41	11	15	0	NE	53	Dead	CMV Pn
42	16	51	II	0	168	CR
43	17	18	0	0	120	CR
44	14	—	II	0	109	PR
45	15	20	0	0	108	CR
46	13	20	III	NE	99	NE
47	16	11	II	NE	79	NE

NE indicates not evaluated; IP, idiopathic pneumonitis; Prog, disease progression; DU, duodenal ulcer; IFI, invasive fungal infection; PFIII, parainfluenza III; EBV LPD, EBV-related lymphoproliferative disorder; CMV Pn, CMV pneumonitis; for other abbreviations, see Table 1.

Further significant disease response after transplantation.

†

Primary graft failure.

View Large

This Feature Is Available To Subscribers Only